Plaque Psoriasis Research Study (24 Weeks)

Males and females aged 18 to 70 years old with a history of moderate to severe plaque psoriasis for at least 6 months, may qualify to participate. Individuals must have plaque-type psoriasis covering 10% or more of their body surface area, and a body mass index (BMI) less than or equal to 40 kg/m2. UV therapy is restricted during the 28 days prior to study enrollment, and for the duration of the study.

Participants will receive investigational oral medication (active study drug) or placebo during the treatment period. Investigational medication and study-related care will be provided at no cost. Participants will receive reimbursement for study-related expenses.

Study participation will last up to 24 weeks and involve about 8 visits to the study centre.

Call the study centre near you, or register now.

Learn more about
Psoriasis
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

MX

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more